Aytu BioPharma Q1 EPS $(1.48) Down From $(1.20) YoY, Sales $22.10M Miss $27.73M Estimate

Aytu BioPharma (NASDAQ:AYTU) reported quarterly losses of $(1.48) per share. This is a 23.33 percent decrease over losses of $(1.20) per share from the same period last year. The company reported quarterly sales of $22.10 million which missed the analyst consensus estimate of $27.73 million by 20.31 percent. This is a 20.09 percent decrease over sales of $27.66 million the same period last year.